Skip to main content
Clinical Trials/NCT05502874
NCT05502874
Not Yet Recruiting
N/A

Multicenter Registry for Assessment of Markers of Early Neurological Deterioration in Primary Intracerebral Hemorrhage

Second Affiliated Hospital, School of Medicine, Zhejiang University1 site in 1 country1,600 target enrollmentSeptember 1, 2022

Overview

Phase
N/A
Intervention
Not specified
Conditions
Intracerebral Hemorrhage
Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University
Enrollment
1600
Locations
1
Primary Endpoint
Early neurological deterioration (END)
Status
Not Yet Recruiting
Last Updated
3 years ago

Overview

Brief Summary

This multicenter observational study will explore the risk factors of early neurological deterioration(END) in patients with primary and to investigate the association between END and outcome.

Detailed Description

Neurological deterioration affects approximately one-third of patients with primary intracerebral hemorrhage (ICH) and increases the risk of death and dependency. However, the risk factors of early neurological deterioration (END), such as biochemical parameters, neuroimaging, and systemic complications, are not well documented in primary ICH, and the effective predictors of END is unknown. This multicenter observational study aims to seek out the risk factors of END in patients with primary ICH and to investigate the association between END and outcome.

Registry
clinicaltrials.gov
Start Date
September 1, 2022
End Date
October 1, 2025
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Confirmed diagnosis of primary intracerebral hemorrhage

Exclusion Criteria

  • Patients with secondary
  • Undergo surgical evacuation of hematoma;
  • Presenting contraindications or refusal to MRI
  • Is pregnant
  • Patients refuse to be followed up for any reasons.

Outcomes

Primary Outcomes

Early neurological deterioration (END)

Time Frame: 48 hours after admission

END is defined as an increase in the total NIHSS score of ≥ 4 points within the first 48 h after admission

Secondary Outcomes

  • The quality of life(90 days, 1 year, 2 years after admission)
  • Late neurological deterioration (LND)(7 days)
  • Cognitive function(90 days, 1 year, 2 years after admission)
  • Functional outcome(90 days, 1 year, 2 years after admission)
  • Hematoma expansion(24 hours after admission)
  • Depression status(90 days, 1 year, 2 years after admission)

Study Sites (1)

Loading locations...

Similar Trials